Evidence map›Paper›PMID 27564380›Full record

ArticlePloS one2016

Combined B, T and NK Cell Deficiency Accelerates Atherosclerosis in BALB/c Mice.

Fei Cheng, Laura Twardowski, Kurt Reifenberg, Kerstin Winter, Antje Canisius, Eva Pross, Jianglin Fan, Edgar Schmitt, Leonard D Shultz, Karl J Lackner and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. NSG Mice Lacking Apoe: An Immunodeficient Mouse Model of Atherosclerosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Inflammation and Immune Mechanisms in Atherosclerosis.Reviews in cardiovascular medicine · 2026
    Review
  3. Observational
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

Fei ChengDr. Margarete Fischer-Institute of Clinical Pharmacology, Stuttgart and University of Tübingen, Tübingen, Germany.
Laura TwardowskiDepartment of Laboratory Medicine, Robert-Bosch-Hospital, Stuttgart, Germany.
Kurt ReifenbergCenter for Preclinical Research, German Cancer Research Center, Heidelberg, Germany.
Kerstin WinterDr. Margarete Fischer-Institute of Clinical Pharmacology, Stuttgart and University of Tübingen, Tübingen, Germany.
Antje CanisiusInstitute of Clinical Chemistry and Laboratory Medicine, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
Eva ProssDr. Margarete Fischer-Institute of Clinical Pharmacology, Stuttgart and University of Tübingen, Tübingen, Germany.
Jianglin FanDepartment of Molecular Pathology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Yamanashi, Japan.
Edgar SchmittInstitute for Immunology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
Leonard D ShultzThe Jackson Laboratory, Bar Harbor, Maine, United State of America.
Karl J LacknerInstitute of Clinical Chemistry and Laboratory Medicine, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
Michael TorzewskiDepartment of Laboratory Medicine, Robert-Bosch-Hospital, Stuttgart, Germany.
Johannes Gutenberg University Mainz · DEDr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology · DERobert Bosch Hospital · DEGerman Cancer Research Center · DEJackson Laboratory · USUniversity of Tübingen · DEUniversity of Yamanashi · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study focused on the unique properties of both the Ldlr knockout defect (closely mimicking the human situation) and the BALB/c (C) inbred mouse strain (Th-2 slanted immune response). We generated two immunodeficient strains with severe combined B- and T-cell immunodeficiency with or without a complete lack of natural killer cells to revisit the role of adaptive immune responses on atherogenesis. C-Ldlr-/- Rag1-/- mice, which show severe combined B- and T-cell immunodeficiency and C-Ldlr-/- Rag1-/- Il2rg-/- mice, which combine the T- and B-cell defect with a complete lack of natural killer cells and inactivation of multiple cytokine signalling pathways were fed an atherogenic Western type diet (WTD). Both B6-Ldlr-/- and C-Ldlr-/- immunocompetent mice were used as controls. Body weights and serum cholesterol levels of both immunodeficient strains were significantly increased compared to C-Ldlr-/- controls, except for cholesterol levels of C-Ldlr-/- Rag1-/- double mutants after 12 weeks on the WTD. Quantification of the aortic sinus plaque area revealed that both strains of immunodeficient mice developed significantly more atherosclerosis compared to C-Ldlr-/- controls after 24 weeks on the WTD. Increased atherosclerotic lesion development in C-Ldlr-/- Rag1-/- Il2rg-/- triple mutants was associated with significantly increased numbers of macrophages and significantly decreased numbers of smooth muscle cells compared to both C-Ldlr-/- wild type and C-Ldlr-/- Rag1-/- double mutants pointing to a plaque destabilizing effect of NK cell loss. Collectively, the present study reveals a previously unappreciated complexity with regard to the impact of lymphocytes on lipoprotein metabolism and the role of lymphocyte subsets in plaque composition.

Indexed as

Adaptive ImmunityAnimalsAtherosclerosisB-LymphocytesCholesterolFemaleImmune SystemImmunologic Deficiency SyndromesKiller Cells, NaturalLipoproteinsMiceMice, Inbred BALB CMice, KnockoutMutationPhenotypePlaque, AtheroscleroticCholesterolLipoproteinsReceptors, LDLTriglycerides

Identifiers

PMID27564380
PMCPMC5001715
OpenAlexW2515362470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.